Acute Myeloid Leukemia Committee (AML)

Committee Chairman:

Henrik Hasle

Committee Members:

N/A

Clinical Trials:

Open:

ICC APL Study 01
Down Syndrome ML 2006
Relapsed AML 2010/01 (start Dec 2012)

Completed:

Methotrexate in relapsed and refractory childhood AML – a therapeutic window study (1999-2003)
Relapsed AML 2001/01 (2001-2009)
A phase II study on Mylotarg in childhood relapsed and refractory AML (2002-2006)

Activities/Projects:

N/A

Recent Publications:

Rooij, Jasmijn D E de, Branstetter, Cristyn, Zwaan, C Michel, et al. “Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes“, Nature Genetics,  1061-4036, 2017, https://dx.doi.org/10.1038/ng.3772

Meetings:

Recent:

December 4th 2016, San Diego, USA

Next:

N/A

Contact:

Henrik Hasle    hasle@dadlnet.dk